Palmar plantar erythrodysesthesia overview: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Mchitsazan (talk | contribs) |
||
| Line 5: | Line 5: | ||
==Historical Perspective== | ==Historical Perspective== | ||
In 1974, Zuehlke was the first to describe PPE in a patient receiving mitotane for hypernephroma. | |||
==Classification== | ==Classification== | ||
Revision as of 16:11, 2 July 2019
|
Palmar plantar erythrodysesthesia Microchapters |
|
Differentiating Palmar plantar erythrodysesthesia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Palmar plantar erythrodysesthesia overview On the Web |
|
American Roentgen Ray Society Images of Palmar plantar erythrodysesthesia overview |
|
Directions to Hospitals Treating Palmar plantar erythrodysesthesia |
|
Risk calculators and risk factors for Palmar plantar erythrodysesthesia overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Historical Perspective
In 1974, Zuehlke was the first to describe PPE in a patient receiving mitotane for hypernephroma.